Henry Schein, Inc. HSIC
86.37
0.84
0.98%
as of 25 Sep
- Market cap
- $9.5B
- P/E
- 25.0×
Follow HSIC
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Henry Schein, Inc. (HSIC) P/S ratio
As of 25 September 2026, Henry Schein, Inc. (HSIC) trades at a P/S ratio of 0.7×. Over the past ten years it has ranged from 0.6× (October 2025) to 1.6× (December 2018); the current reading is higher than 18% of that period. That is above the Medical Distribution industry median of 0.2× and below the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 0.7× | 0.04% |
| FY2024 | 0.7× | (13.45%) |
| FY2023 | 0.8× | (6.60%) |
| FY2022 | 0.9× | (2.22%) |
| FY2021 | 0.9× | (6.99%) |
| FY2020 | 0.9× | (4.66%) |
| FY2019 | 1.0× | (1.06%) |
| FY2018 | 1.0× | 0.91% |
| FY2017 | 1.0× | 15.80% |
| FY2016 | 0.9× | (11.66%) |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 0.7× | 10.06% |
| Mar 2026 | 0.6× | (8.62%) |
| Dec 2025 | 0.7× | 12.33% |
| Sep 2025 | 0.6× | (11.57%) |
| 42 more quarters | Free account |
Against its own ten years
Low 0.6×
High 1.6×
Ten-year median
0.9×
Current reading's percentile
18
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| YI 111, Inc. Sponsored ADR compare | 0.0× |
| ACH Accendra Health, Inc. compare | 0.0× |
| COR Cencora, Inc. compare | 0.2× |
| CAH Cardinal Health, Inc. compare | 0.2× |
| MCK McKesson Corporation compare | 0.3× |
| COSM Cosmos Health Inc. compare | 0.3× |
| HSIC Henry Schein, Inc. | 0.7× |
| AHG Akso Health Group Sponsored ADR compare | 0.9× |
| FOCL FocalTherics compare | 2.2× |
| Medical Distribution industry median | 0.2× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on HSIC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement